The enzyme Bruton tyrosine kinase (BTK) is involved in B-cell signaling that promotes the migration, proliferation, and survival of neoplastic B-cells of patients with chronic lymphocytic leukemia (CLL) [1]. Here, BTK is linked to B-cell chronic lymphocytic leukemia.